A39.2

Clinical Causes: Infection with Neisseria meningitidis bacteria, often through respiratory droplets or close contact with an infected person. Exposure to environments where the bacteria are prevalent, such as crowded living conditions, military barracks, or college dormitories. Presence of certain risk factors like a weakened immune system, age (most common in infants, adolescents, and young adults), or certain medical conditions. Travel to regions where meningococcal disease is endemic.

Key Symptoms: Sudden high fever Severe headache Neck stiffness and pain Nausea and vomiting Sensitivity to light (photophobia) Confusion or altered mental status Skin rash that may appear as purple or red spots, indicating bleeding under the skin Fatigue and general malaise Cold hands and feet in some cases Rapid breathing

Diagnosis Path: Diagnosis of acute meningococcemia involves a combination of clinical assessment and laboratory testing. Healthcare providers typically perform blood cultures to identify Neisseria meningitidis. Cerebrospinal fluid analysis may also be conducted via lumbar puncture to detect meningitis. Blood tests may show evidence of infection and inflammation, such as increased white blood cell count. Imaging studies are generally not required but can be used to evaluate complications.

Treatment Protocols: Treatment of acute meningococcemia is an urgent medical matter, involving immediate administration of antibiotics to eliminate the bacteria. Common antibiotics include penicillin or third-generation cephalosporins, administered intravenously. Supportive care in an intensive care setting may be necessary to manage complications, including intravenous fluids, corticosteroids, or medications to support blood pressure. Preventive measures like vaccination are also essential in reducing the risk of infection, especially for those at higher risk. Close monitoring for signs of disseminated intravascular coagulation or organ failure is vital during treatment.